In addition, visceral obesity is expected to increase post-operative morbidity, because visceral adipose tissue secretes a number of adipokines and cytokines leading to a proinflammatory, procoagulant, and an insulin-resistant state, collectively known as the metabolic syndrome [27,28]. This evidence concerns the gene INS and metabolic syndrome.